CONMED EBITDA 2011-2025 | CNMD
CONMED ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
CONMED Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $278 |
| 2023 | $199 |
| 2022 | $144 |
| 2021 | $194 |
| 2020 | $132 |
| 2019 | $163 |
| 2018 | $133 |
| 2017 | $105 |
| 2016 | $93 |
| 2015 | $95 |
| 2014 | $99 |
| 2013 | $104 |
| 2012 | $112 |
| 2011 | $111 |
| 2010 | $99 |
|
CONMED Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $58 |
| 2025-03-31 | $36 |
| 2024-12-31 | $72 |
| 2024-09-30 | $85 |
| 2024-06-30 | $66 |
| 2024-03-31 | $54 |
| 2023-12-31 | $70 |
| 2023-09-30 | $50 |
| 2023-06-30 | $47 |
| 2023-03-31 | $32 |
| 2022-12-31 | $18 |
| 2022-09-30 | $43 |
| 2022-06-30 | $43 |
| 2022-03-31 | $40 |
| 2021-12-31 | $58 |
| 2021-09-30 | $47 |
| 2021-06-30 | $47 |
| 2021-03-31 | $42 |
| 2020-12-31 | $46 |
| 2020-09-30 | $51 |
| 2020-06-30 | $0 |
| 2020-03-31 | $35 |
| 2019-12-31 | $50 |
| 2019-09-30 | $43 |
| 2019-06-30 | $40 |
| 2019-03-31 | $30 |
| 2018-12-31 | $41 |
| 2018-09-30 | $27 |
| 2018-06-30 | $32 |
| 2018-03-31 | $33 |
| 2017-12-31 | $39 |
| 2017-09-30 | $28 |
| 2017-06-30 | $27 |
| 2017-03-31 | $11 |
| 2016-12-31 | $27 |
| 2016-09-30 | $28 |
| 2016-06-30 | $22 |
| 2016-03-31 | $17 |
| 2015-12-31 | $25 |
| 2015-09-30 | $26 |
| 2015-06-30 | $23 |
| 2015-03-31 | $21 |
| 2014-12-31 | $29 |
| 2014-09-30 | $14 |
| 2014-06-30 | $27 |
| 2014-03-31 | $28 |
| 2013-12-31 | $29 |
| 2013-09-30 | $21 |
| 2013-06-30 | $28 |
| 2013-03-31 | $28 |
| 2012-12-31 | $29 |
| 2012-09-30 | $26 |
| 2012-06-30 | $28 |
| 2012-03-31 | $29 |
| 2011-12-31 | $30 |
| 2011-09-30 | $27 |
| 2011-06-30 | $27 |
| 2011-03-31 | $28 |
| 2010-12-31 | $24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.376B | $1.307B |
| CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.013B | 23.28 |
| Becton Dickinson (BDX) | United States | $50.558B | 12.36 |
| Cardinal Health (CAH) | United States | $46.756B | 22.09 |
| West Pharmaceutical Services (WST) | United States | $20.399B | 40.10 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.119B | 0.00 |
| Cooper (COO) | United States | $13.694B | 17.13 |
| Align Technology (ALGN) | United States | $9.946B | 18.59 |
| Henry Schein (HSIC) | United States | $8.477B | 14.94 |
| Merit Medical Systems (MMSI) | United States | $5.165B | 25.40 |
| DENTSPLY SIRONA (XRAY) | United States | $2.517B | 7.38 |
| STAAR Surgical (STAA) | United States | $1.246B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.106B | 12.59 |
| Lifevantage (LFVN) | United States | $0.093B | 8.81 |